• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Invima Approves ORLADEYO for HAE Prevention in Colombia

    BUSINESSWIRE

    ORLADEYO® (berotralstat) Approved in Colombia

    GLOBENEWSWIRE

    Pint Pharma Announces ORLADEYO Approval For HAE In Peru

    BUSINESSWIRE

    Pint Pharma Announces ORLADEYO Approval In Mexico For HAE

    BUSINESSWIRE

    Brazil Approves Pint`s ORLADEYO® For HAE In Adults, Kids ?12 Yrs

    BUSINESSWIRE

    Empaveli is the first treatment for PNH that binds to the complement protein C3.

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.